California may soon drive a hole through Washington’s tolerance for — and protection of — price gouging on drugs. A measure on the November ballot, Proposition 61, would bar state agencies from paying more for prescription drugs than the U.S. Department of Veterans Affairs does.
Calling Valeant a “drug company” is problematic because it’s not much into researching and developing new medications. “Bet on management, not on science,” its outgoing CEO, J. Michael Pearson, was fond of saying.
Yes, the drugmakers know how to make government work for them. No other Western country lets drug companies charge whatever they think they can get away with.
Martin Shkreli has also done the American people a service by showing in high def how the pharmaceutical industry gouges us on a regular basis.